Galectin Therapeutics (GALT) Cash from Investing Activities (2011 - 2014)
Galectin Therapeutics' (GALT) quarterly Cash from Investing Activities came in at -$400000.0 in Q1 2014, down 814.29% quarter-over-quarter from $56000.0 in Q4 2012.
Galectin Therapeutics (GALT) Cash from Investing Activities (2011 - 2014) Analysis & Trends
Galectin Therapeutics' Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$400000.0 for Q1 2014.
- On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$400000.0 in Q1 2014; TTM through Dec 2014 was -$400000.0, a N/A change from a year earlier, with the FY2014 full-year figure at -$400000.0, changed N/A from the prior year.
- Cash from Investing Activities retreated to -$400000.0 in Q1 2014 per GALT's latest filing, from $56000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $56000.0 in Q4 2012 and bottomed at -$400000.0 in Q1 2014.
- The 3-year median for Cash from Investing Activities is -$5000.0 (2011), against an average of -$88500.0.
- Biggest YoY gain for Cash from Investing Activities was 1220.0% in 2012; the steepest drop was 1220.0% in 2012.
- Year by year, Cash from Investing Activities stood at -$5000.0 in 2011, then soared by 1220.0% to $56000.0 in 2012, then tumbled by 814.29% to -$400000.0 in 2014.
- Per Business Quant, the three latest GALT Cash from Investing Activities figures stand at -$400000.0 (Q1 2014), $56000.0 (Q4 2012), and -$5000.0 (Q4 2011).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - | 172.62 Mn |
| 10 | Galectin Therapeutics | 223.33 Mn | 223.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | -400,000.00 |
| Mar 31, 2014 | -400,000.00 |
| Dec 31, 2012 | 56,000.00 |
| Dec 31, 2012 | 56,000.00 |
| Dec 31, 2011 | -5,000.00 |
| Dec 31, 2011 | -5,000.00 |
| Sep 30, 2011 | -5,000.00 |
| Sep 30, 2011 | -5,000.00 |